Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Recruiting · NCT04588077 · Registry updated 2024-11-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis | Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Fibrosis, Hepadnaviridae infectious disease, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 4 | 2024-11-19 | NCT04588077 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mercy Medical Center | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mercy Medical Center | Baltimore | United States | 40 |